Milanese M, Terraneo S, Baiardini I, Di Marco F, Corsico A, Molino A, Scichilone N
Department of Medicine, Respiratory Unit, ASL2 Savonese, Savona, Italy.
Respiratory Unit, ASST Santi Paolo e Carlo, Milan, Italy.
World Allergy Organ J. 2019 Jun 20;12(6):100040. doi: 10.1016/j.waojou.2019.100040. eCollection 2019.
Adherence to inhaled drugs is linked to patients' satisfaction with their device, and an incorrect use can negatively affect the outcomes of asthma treatment. We speculated that this is particularly true in elderly asthmatic subjects.
We performed a national pre-post interventional multicentre study, enrolling moderate-to-severe asthmatic subjects aged ≥65 years treated with fixed inhaled combination drugs by dry powder inhaler (DPI) or pressurized metered dose inhaler (pMDI). Adherence and critical errors were evaluated by means of validated questionnaires at first visit (V1) and after 3-6 months (V2). At V1, subjects underwent intensive training on the correct use of their device by physical demonstration.
A total of 411 asthmatics (F/M: 238/173, mean age±SD: 72 ± 5 years) participated to the study. At V1, 50% of the study subjects showed an Asthma Control Test (ACT) score ≤19 despite GINA step 3 and 4 treatment, and 40% had experienced at least one severe asthma exacerbation in the previous year. Poor adherence to treatment was recorded in 43% of subjects, and at least one error in using the device was registered in 56% of subjects. At V2, available for 318 patients, both the percentage of individuals with poor adherence and with at least one critical error significantly decreased (from 46% to 25%, and from 49% to 25%, respectively; p < 0.001 for both comparisons) with a significant increase of the ACT score (from 19 ± 4.9 to 20 ± 4.0, p < 0.001).
Asthma in the elderly is characterized by low levels of symptom control. Educational interventions are strongly advocated in this age group in order to increase adherence to treatment and inhaler techniques.
吸入药物的依从性与患者对其使用装置的满意度相关,且不正确的使用会对哮喘治疗效果产生负面影响。我们推测这在老年哮喘患者中尤为如此。
我们开展了一项全国性的干预前后多中心研究,纳入年龄≥65岁、使用干粉吸入器(DPI)或压力定量吸入器(pMDI)接受固定吸入复方药物治疗的中重度哮喘患者。在首次就诊(V1)时和3至6个月后(V2),通过经过验证的问卷评估依从性和关键错误。在V1时,通过实际演示对受试者进行了关于正确使用其装置的强化培训。
共有411名哮喘患者(男/女:238/173,平均年龄±标准差:72±5岁)参与了该研究。在V1时,尽管接受了全球哮喘防治创议(GINA)第3和第4级治疗,但50%的研究对象哮喘控制测试(ACT)得分≤19,且40%的患者在前一年至少经历过一次严重哮喘发作。43%的受试者记录了治疗依从性差,56%的受试者记录了至少一项装置使用错误。在V2时,318名患者的数据可用,依从性差和至少有一项关键错误的个体百分比均显著下降(分别从46%降至25%,从49%降至25%;两项比较p均<0.001),ACT得分显著提高(从19±4.9提高到20±4.0,p<0.001)。
老年哮喘的特点是症状控制水平低。强烈建议对该年龄组进行教育干预,以提高治疗依从性和吸入技术。